Scalper1 News
Device maker St. Jude Medical (STJ) met Wall Street’s expectations with its Q1 results and guidance Wednesday, but the stock was down 3% in morning trading on the stock market today. St. Jude’s sales rose 2% over the year-earlier quarter to $1.36 billion, matching analysts’ consensus. Earnings climbed 4% to 96 cents a share, a penny over estimates. But that was due to lower taxes, according to analysts. The company said Q2 revenue should be $1.38 Scalper1 News
Scalper1 News